NASDAQ · Biotechnology

Oramed Pharmaceuticals Inc. (ORMP) Stock

$4.20 -3.89% NASDAQ: ORMP Healthcare

Valuation

MetricValue
Price$4.20
Market Cap$171.89M
P/E Ratio1.06
P/B Ratio0.58
P/S Ratio91.88
EPS (TTM)$1.50
52-Week High$5.47
52-Week Low$2.09
Dividend Yield22.27%

Financials & Margins

MetricValue
ROE72.96%
ROA47.31%
ROCE-4.05%
Gross Margin-750.00%
Operating Margin-750.00%
Net Margin3200.00%
Debt/Equity0.01
Current Ratio7.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.0M$3.0M$1.0M$0$2.0M
Operating Profit$-24.0M$-41.0M$-16.0M$-13.0M$-15.0M
Net Profit$-22.0M$-38.0M$6.0M$-19.0M$64.0M
EPS$-0.78$-0.97$0.14$-0.48$1.50
Op Margin-896.1%-1502.0%-1176.8%—-754.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$128.0M$162.0M$221.0M$155.0M$231.0M
Total Liabilities$11.0M$10.0M$58.0M$10.0M$31.0M
Cash$77.0M$40.0M$9.0M$54.0M$46.0M
Borrowings$1.0M$1.0M$52.0M$0$1.0M

Latest News

Lifeward Enters Securities Purchase Agreement Under Oramed Financing Framework MT Newswires · Jul 7, 2026 Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing GlobeNewswire · Jul 7, 2026 Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet PR Newswire · Jun 25, 2026 ORMP: View Inclusion in Russell Indexes as Positive That Could Raise Awareness in Investment Community Zacks Small Cap Research · Jun 18, 2026 Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes PR Newswire · Jun 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-21.0M$-29.0M$-10.0M$-8.0M$-9.0M
Investing Cash Flow$-23.0M$30.0M$-73.0M$106.0M$4.0M
Financing Cash Flow$0$0$0$-2.0M$-5.0M
Net Cash Flow$58.0M$-37.0M$-31.0M$45.0M$-8.0M
Free Cash Flow$-22.0M$-29.0M$-11.0M$-8.0M$-11.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA1.11
FCF Yield-2.92%
Quick Ratio4.98
Interest Coverage0.00
Return 1Y101.44%
Return 3Y33.67%
Return 5Y-66.21%

Ownership

Insiders Held17.93%
Institutions Held31.65%
Institutions Float Held38.57%
Institutional HolderSharesReport Date
BML Capital Management, LLC3,167,2312026-03-31
Aquamarine Financial (cayman) Ltd2,112,3122026-03-31
Mercer Global Advisors, Inc./ADV1,910,5402026-03-31
Gem Investment Advisors, LLC1,640,0692026-03-31
Murchinson Ltd.1,315,2942026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLNNClene Inc. $3.88 -1.02% -1.10 $49.58M 0.00%
CNTBConnect Biopharma Holdings Limited $0.88 -6.77% -1.05 $55.45M 0.00%
CNTXContext Therapeutics Inc. $0.30 -4.35% -0.64 $27.47M 0.00%
COYACoya Therapeutics, Inc. $4.99 +1.63% -4.53 $117.05M 0.00%
IFRXInflaRx N.V. $1.53 -1.92% -3.14 $225.36M 0.00%

About Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. is led by CEO Nadav Kidron, employs 13 people, headquartered in US, publicly traded since 2007.

Oramed Pharmaceuticals Inc. (ORMP) stock trades at $4.20 with a market capitalization of $171.89M. The stock is valued at a price-to-earnings (P/E) ratio of 1.06, price-to-book of 0.58, price-to-sales of 91.88. Over the past 52 weeks the stock has ranged between $2.09 and $5.47, and currently trades 23.2% below its 52-week high. It pays a dividend yielding 22.27%.

On profitability, Oramed Pharmaceuticals Inc. generates a return on equity (ROE) of 72.96% — well above the market average, a sign of a high-quality business, return on capital employed of -4.05%, an operating margin of -750.00%, a net profit margin of 3200.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides